@FierceBiotech: UCSF cardiology chief builds a case for two new targets for heart drugs. FierceBiotechResearch article | Follow @FierceBiotech
@JohnCFierce: I'm happy to see $MDVN back in a late-stage development race. It's been awhile, and they're smart, aggressive players. More from FiercePharmaMarketing | Follow @JohnCFierce
> The FDA hopes that adding a simple suffix to a biosimilar name will avoid any confusion about whether the original drug or the knockoff is being prescribed. Story
> South San Francisco-based Exelixis says that Swiss officials have approved cobimetinib for advanced melanoma--a regulatory first. Release
Medical Device News
@FierceMedDev: Israeli nitric oxide drug-device player files for up to $36M Nasdaq IPO. Article | Follow @FierceMedDev
@VarunSaxena2: Providence Medical receives $12M in financing to expand sales of its spinal fusion devices. Story | Follow @VarunSaxena2
@EmilyWFierce: Recipharm strikes development deal for RedHill's bacteria-fighter candidate. FierceCRO item | Follow @EmilyWFierce
> Greatbatch grabs Lake Regional Medical for $730M to expand surgical offerings. News
> Abbott denies FT report that it's preparing $25B bid for St. Jude Medical. Article
Pharma News
@FiercePharma: Academic docs and biotechs partner with veterinarians to find cancer cures. More from FierceAnimalHealth | Follow @FiercePharma
@CarlyHFierce: Can Sprout's Addyi shrug off serious side effects? These blockbusters did. FiercePharmaMarketing article | Follow @CarlyHFierce
> Impatient Horizon accuses Depomed of stalling its shareholder meeting plans. Report
> AbbVie scores one against FTC in pay-for-delay AndroGel suit. News
> Lilly, Boehringer amp up fight against Lantus with U.K. biosim launch. Article
Vaccines News
> Pfizer's Trumenba shows 'robust' MenB protection in two PhIII trials. News
> Valneva licenses EB66 technology to develop human, veterinary vaccines. Report
> Takeda expands vaccine platform rights with Nanotherapeutics agreement. More
> FluGen reels in $12M to fund PhI of its universal flu jab. Story
> Scripps Research Institute, J&J test 'universal' flu vaccine in mice, monkeys. Article
CRO News
> WuXi inks lab testing pact with Chinese Lee's Pharm. News
> Germany lists 54 GVK suspensions as EU comes down on Indian CRO. More
> Recipharm strikes development deal for RedHill's bacteria-fighter candidate. Report
> CRO field to grow nearly 10% annually through 2019, report says. Story
> India's Accutest Research Labs expands into Latin America. Article
Pharma Manufacturing News
> Shire works deal with Sanquin so it can boost production of rare disease drug. More
> Woodcock says FDA will keep new plant quality grades a secret. Report
> Sterilization specialist on expansion streak. Item
> Sucampo gets control of Amitiza production in deal for Japanese company. Story
> Novo picks Clayton, NC, for its first U.S. API plant. Article
Pharma Asia News
> India's Gujarat state moves closer to country's first medical device testing lab. Story
> China's Shenzhen Hepalink keeps N. American deal stream rolling with Cytovance. More
> Oncology trials in China may see pilot program for 60-day IND decision. Story
> BD Life Science buys Silicon Valley-based Cellular Research, part of Decheng portfolio. Article
> Japan's PAFSC to review application from Takeda on glatiramer this week. Item